Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List |
|---|
Product Overview | |
| Name | Influenza-A H1N1 New Caledonia |
|---|---|
| Description | |
| H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant | |
| Accession (Primary) | DQ508857 |
| Introduction | |
| Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase. The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope. | |
| Source | |
| Baculovirus Insect Cells. | |
| Physical Appearance | |
| Sterile Filtered colorless solution. | |
| Formulation | |
| The Recombinant B/Ohio/01/05 solution contains 30mM Sodium phosphate, pH 7.4 and 50mM NaCl. | |
| Stability | |
| B/Ohio/01/05 Recombinant should be stored at 4°C. | |
| Purity | |
| Greater than 90.0% as determined by SDS-PAGE. | |
| Immunological Activity | |
| Western-Blot 0.1 µg -1 µg per strip, ELISA 1 µg/Well. | |
| Precautions | |
| Influenza-A H1N1 New Caledonia is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( DQ508857 ) | |
References |
Title : Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection Publication : The Rockefeller University Press , doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link : http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
